JP2025502442A - Ｓｔａｐｈｙｌｏｃｏｃｃｕｓ ｓａｐｒｏｐｈｙｔｉｃｕｓによって引き起こされる感染症の処置における使用のためのゲポチダシンおよびバンコマイシン - Google Patents
Ｓｔａｐｈｙｌｏｃｏｃｃｕｓ ｓａｐｒｏｐｈｙｔｉｃｕｓによって引き起こされる感染症の処置における使用のためのゲポチダシンおよびバンコマイシン Download PDFInfo
- Publication number
- JP2025502442A JP2025502442A JP2024543244A JP2024543244A JP2025502442A JP 2025502442 A JP2025502442 A JP 2025502442A JP 2024543244 A JP2024543244 A JP 2024543244A JP 2024543244 A JP2024543244 A JP 2024543244A JP 2025502442 A JP2025502442 A JP 2025502442A
- Authority
- JP
- Japan
- Prior art keywords
- pharma
- acceptable salt
- vancomycin
- gepotidacin
- ceutically acceptable
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
- A61K38/14—Peptides containing saccharide radicals; Derivatives thereof, e.g. bleomycin, phleomycin, muramylpeptides or vancomycin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/4985—Pyrazines or piperazines ortho- or peri-condensed with heterocyclic ring systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Epidemiology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Engineering & Computer Science (AREA)
- Communicable Diseases (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Gastroenterology & Hepatology (AREA)
- Oncology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Immunology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Peptides Or Proteins (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US202263301522P | 2022-01-21 | 2022-01-21 | |
| US63/301,522 | 2022-01-21 | ||
| PCT/EP2023/051177 WO2023139147A1 (en) | 2022-01-21 | 2023-01-19 | Gepotidacin and vancomycin for use in the treatment of an infection caused by staphylococcus saprophyticus |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2025502442A true JP2025502442A (ja) | 2025-01-24 |
| JPWO2023139147A5 JPWO2023139147A5 (https=) | 2026-01-22 |
| JP2025502442A5 JP2025502442A5 (https=) | 2026-01-22 |
Family
ID=85108785
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2024543244A Pending JP2025502442A (ja) | 2022-01-21 | 2023-01-19 | Ｓｔａｐｈｙｌｏｃｏｃｃｕｓ ｓａｐｒｏｐｈｙｔｉｃｕｓによって引き起こされる感染症の処置における使用のためのゲポチダシンおよびバンコマイシン |
Country Status (6)
| Country | Link |
|---|---|
| US (1) | US20250099535A1 (https=) |
| EP (1) | EP4465989A1 (https=) |
| JP (1) | JP2025502442A (https=) |
| CN (1) | CN118574619A (https=) |
| CA (1) | CA3240991A1 (https=) |
| WO (1) | WO2023139147A1 (https=) |
Family Cites Families (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EA015821B1 (ru) | 2007-04-20 | 2011-12-30 | Глэксо Груп Лимитед | Трициклические азотсодержащие соединения в качестве антибактериальных агентов |
| WO2020201833A1 (en) * | 2019-04-03 | 2020-10-08 | Glaxomithkline Intellectual Property Development Limited | Gepotidacin for use in the treatment of bacterial urinary tract infections |
-
2023
- 2023-01-19 US US18/728,991 patent/US20250099535A1/en active Pending
- 2023-01-19 JP JP2024543244A patent/JP2025502442A/ja active Pending
- 2023-01-19 EP EP23702056.5A patent/EP4465989A1/en active Pending
- 2023-01-19 WO PCT/EP2023/051177 patent/WO2023139147A1/en not_active Ceased
- 2023-01-19 CA CA3240991A patent/CA3240991A1/en active Pending
- 2023-01-19 CN CN202380017824.7A patent/CN118574619A/zh active Pending
Also Published As
| Publication number | Publication date |
|---|---|
| CN118574619A (zh) | 2024-08-30 |
| US20250099535A1 (en) | 2025-03-27 |
| WO2023139147A1 (en) | 2023-07-27 |
| CA3240991A1 (en) | 2023-07-27 |
| EP4465989A1 (en) | 2024-11-27 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| Nichols et al. | Effect of preoperative neomycin-erythromycin intestinal preparation on the incidence of infectious complications following colon surgery | |
| Grüneberg et al. | The comparative in-vitro activity of ofloxacin | |
| JP2025084772A (ja) | 細菌性尿路感染症の治療に使用するためのゲポチダシン | |
| US9839634B2 (en) | Antibacterial agents: combination of a rifamycin and a switch region inhibitor | |
| EP3993796B1 (en) | Combination for the treatment of infections caused by mycoplasma genitalium | |
| WO2014080378A1 (en) | Phenothiazine derivatives and their use against tuberculosis | |
| KR20200026118A (ko) | 헬리코박터 파일로리 제균용 조성물 | |
| BRPI0916885B1 (pt) | composição farmacêutica | |
| JP2025508098A (ja) | 抗特発性肺線維症薬ニンテダニブの結核を治療するための使用 | |
| JP2025502442A (ja) | Ｓｔａｐｈｙｌｏｃｏｃｃｕｓ ｓａｐｒｏｐｈｙｔｉｃｕｓによって引き起こされる感染症の処置における使用のためのゲポチダシンおよびバンコマイシン | |
| JP2025131626A (ja) | ゲポチダシンを用いて淋菌感染症を治療するためのレジメン | |
| CN106029068A (zh) | 包含抗菌剂的药物组合 | |
| US6803376B1 (en) | Method of use of quinolone compounds against pneumococcal and haemophilus bacteria | |
| CN115778936A (zh) | 松萝酸协同增效多黏菌素在抗革兰氏阴性细菌感染中的应用 | |
| US20220184071A1 (en) | Gepotidacin for use in the treatment of bacterial urinary tract infections | |
| CN106163519A (zh) | 包含抗菌剂的药物组合物 | |
| US20240108620A1 (en) | Treatment Regimen | |
| JP2022551228A (ja) | 抗生物質併用療法 | |
| CN106102741A (zh) | 包含抗菌剂的药物组合物 | |
| EP4593835A1 (en) | Gepotidacin for use in the treatment of bacterial prostatitis | |
| EP3294317B1 (en) | Enhanced antibiotic composition | |
| Weigelt et al. | Use of quinolones in surgery and obstetrics and gynecology | |
| CN121648123A (zh) | 一种用于增强抗菌剂对肺部细菌感染治疗效果的药物 | |
| JP2008534443A (ja) | 新規な方法 | |
| Richard | Cystitis in women treatment with levofloxacin preparations. Application of levofloxacin in urological practice |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| A521 | Request for written amendment filed |
Free format text: JAPANESE INTERMEDIATE CODE: A523 Effective date: 20260114 |
|
| A621 | Written request for application examination |
Free format text: JAPANESE INTERMEDIATE CODE: A621 Effective date: 20260114 |